Treatment options for patients with recurrent Graves hyperthyroidism after anti-thyroid drug treatment
10.3760/cma.j.issn.1000-6699.2019.10.019
- VernacularTitle:抗甲状腺药物治疗后Graves甲亢复发患者的治疗方案选择
- Author:
Mengsi LIU
1
;
Jia LIU
;
Guang WANG
Author Information
1. 北京市第六医院老年干部科 100007
- Keywords:
Hyperthyroidism;
Graves'disease;
Anti-thyroid drugs;
Recurrence
- From:
Chinese Journal of Endocrinology and Metabolism
2019;35(10):903-906
- CountryChina
- Language:Chinese
-
Abstract:
Graves'disease (GD) is the most common cause of hyperthyroidism, and its treatment includes anti-thyroid drugs (ATD), radioactive iodine therapy (RAI), and surgical treatment. ATD is the first choice for GD treatment in China, but the high recurrence rate limits its widely clinical application. The therapeutic strategy for patients with recurrent hyperthyroidism after ATD treatment is still controversial.
